Eli Lilly expects to start selling its weight-loss drug in Hong Kong as early as the end of this year, Bloomberg News ...

Semaglutide may reduce Alzheimer's risk in type 2 diabetes patients, with research suggesting significant protective benefits ...

Semaglutide, the diabetes drug also known as Ozempic, has shown positive effects in treating patients with chronic kidney ...

Pharmaceuticals’ New Drug Application #210934, for sotagliflozin oral tablet, as an adjunct to insulin therapy, to improve ...

Lizzo is getting in on the joke with a new Halloween costume that spoofs a bit from 'South Park: The End of Obesity.' ...

Learn how to grow your wealth through smart investing strategies and financial planning in this informative article by a ...

Online health platforms continue to advertise access to copycat versions of blockbuster weight-loss drugs Wegovy and Zepbound despite the long-term threat to business.

Elizabeth Zachariah examines how the blockbluster success of Ozempic is shaping the global pharmaceutical landscape ...

An Inverness woman is paying more than £200-a-month for medication to treat her Type 2 diabetes because doctors have told her ...

The CDSCO has also identified 67 additional medications that were classified as Not of Standard Quality (NSQ) due to their ...

Eli Lilly stock has soared on a new growth wave driven by its diabetes and obesity care treatments. While this has made profit-taking in Lilly stock tempting, the company has several catalysts ahead.

A TikToker and nutrition expert shares how to tell if a drink contains sugar, following the recall of Minute Maid zero sugar lemonade.